Serenus.AI News
4 articles
growth-positive
Serenus.AI Granted New US Patent for 'AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES'
Serenus.AI, an innovative startup developing AI-based solutions to improve medical treatment decisions, has obtained a Notice of Allowance from the US Patent and Trademark Office for its patent application. The patent focuses on screening and prevention of unnecessary medical procedures. This adds to Serenus.AIs intellectual property portfolio and highlights the companys uniqueness and innovation in the US healthcare market. The problem of unnecessary medical procedures is a burden on healthcare systems, especially during emergencies like the COVID-19 pandemic. Serenus.AI aims to improve healthcare delivery, minimize risks, and save valuable resources. The companys flagship product is an AI-based review system to improve utilization and prior authorization processes before medical procedures. Serenus.AI has a world-class team and is currently active in Europe and the US with leading healthcare stakeholders.
CustomersPartners
growth-positive
Serenus.AI - Innovative AI-based technology for improved medical treatment decisions
Serenus.AI Ltd., an AI-based healthcare solution provider, has developed a platform that assists patients, medical professionals, health systems, and insurers in making better medical treatment decisions. The platform uses unique algorithms to replicate the decision-making process of top physicians, combining medical practice guidance, professionals knowledge, and machine learning technologies. Serenus.AI has recently partnered with HealthTrio to launch an AI Prior-Auth Connect solution, aimed at simplifying medical pre-authorization clinical decision making. The company has already developed modules for 30 common and costly elective procedures, reducing medical and administrative costs for customers. Serenus.AI is active in Israel, the USA, and the UK and has received awards and grants for its innovative technology.
CustomersPartners
growth-positive
Serenus.AI and HealthTrio team up to innovate the authorization process through the use of advanced machine learning
Serenus.AI and HealthTrio LLC are partnering to launch AI Prior-Auth Connect, a platform that uses AI technologies to streamline and automate the process for medical prior authorizations. The collaboration aims to improve and simplify the healthcare process, advance quality of care, and save valuable resources. The platform will enable providers and payers to streamline the authorizations process, allowing faster and more accurate responses based on customizable plan policy. Serenus.AI is an innovative startup focused on optimizing medical decisions, while HealthTrio provides digital engagement solutions for healthcare consumerism. The partnership combines their expertise to deliver a solution that takes the healthcare system to the next level.
Partners
BIRD to invest $8 Million in 10 New Projects - BIRD Foundation
